Skip to main content
Home / Current Medicinal Chemistry, Volume 24, Number 14
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 24, Number 14, 2017

Articles

Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer
pp. 1383-1402(20)
Authors: Pancione, Massimo; Giordano, Guido; Parcesepe, Pietro; Cerulo, Luigi; Coppola, Luigi; Del Curatolo, Anais; Conciatori, Fabiana; Milella, Michele; Porras, Almudena

Favourites:
ADD

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes
pp. 1403-1416(14)
Authors: Liberale, Luca; Montecucco, Fabrizio; G. Camici, Giovanni; Dallegri, Franco; Vecchie, Alessandra; Carbone, Federico; Bonaventura, Aldo

Favourites:
ADD

Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond
pp. 1417-1452(36)
Authors: Ueda, Norishi; Takasawa, Kazuya

Favourites:
ADD

Open Access Therapeutic Strategies of Plant-derived Compounds for Diabetes Via Regulation of Monocyte Chemoattractant Protein-1
pp. 1453-1468(16)
Authors: Czemplik, Magdalena; Kulma, Anna; Fu Wang, Yu; Szopa, Jan

Favourites:
ADD

Role of Oxidative Stress in Renal Transplantation: Bases for an n-3 PUFA Strategy Against Delayed Graft Function
pp. 1469-1485(17)
Authors: G. Sotomayor, Camilo; Cortés, Ignacio; Guillermo Gormaz, Juan; Vera, Sergio; Libuy, Matías; Valls, Nicolás; Rodrigo, Ramón

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content